Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Himmelfarb

Showing results (21-30 of 54) with videos related to

Pageof 6
Sort By:
Molecular & General Genetics : MGG|January 1, 1984
Molecular cloning and biosynthetic regulation of cry1 gene of Saccharomyces cerevisiaeH J Himmelfarb, A Vassarotti, J D Friesen
Journal of the American Society of Nephrology : JASN|October 1, 1991
Intradialytic modulation of granulocyte C5a receptorsJ Himmelfarb, N P Gerard, R M Hakim
Kidney International|March 1, 1997
Increased reticulated platelets in dialysis patientsJ Himmelfarb, D Holbrook, E McMonagle, et al.
Journal of Periodontology|November 13, 2013
Tooth loss strongly associates with malnutrition in chronic kidney diseaseE Ioannidou, H Swede, G Fares, et al.
American Journal of Physiology. Renal Physiology|September 26, 2008
JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cellsA C Breggia, D M Wojchowski, J Himmelfarb
Journal of Vascular Surgery|April 1, 1997
Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferationR Harvey, C E Bredenberg, L Couper, et al.
Molecular and Cellular Biology|June 1, 1987
Isolation and characterization of temperature-sensitive RNA polymerase II mutants of Saccharomyces cerevisiaeH J Himmelfarb, E M Simpson, J D Friesen
Free Radical Biology & Medicine|November 14, 2001
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patientsJ Himmelfarb, M E McMenamin, G Loseto, et al.
Kidney International|May 1, 1994
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind studyR Sreedhara, J Himmelfarb, J M Lazarus, et al.
Cell|December 21, 1990
GAL11P: a yeast mutation that potentiates the effect of weak GAL4-derived activatorsH J Himmelfarb, J Pearlberg, D H Last, et al.
Pageof 6

Showing results (21-30 of 54) with videos related to

Sort By:
Pageof 6
Molecular & General Genetics : MGG|January 1, 1984
Molecular cloning and biosynthetic regulation of cry1 gene of Saccharomyces cerevisiaeH J Himmelfarb, A Vassarotti, J D Friesen
Journal of the American Society of Nephrology : JASN|October 1, 1991
Intradialytic modulation of granulocyte C5a receptorsJ Himmelfarb, N P Gerard, R M Hakim
Kidney International|March 1, 1997
Increased reticulated platelets in dialysis patientsJ Himmelfarb, D Holbrook, E McMonagle, et al.
Journal of Periodontology|November 13, 2013
Tooth loss strongly associates with malnutrition in chronic kidney diseaseE Ioannidou, H Swede, G Fares, et al.
American Journal of Physiology. Renal Physiology|September 26, 2008
JAK2/Y343/STAT5 signaling axis is required for erythropoietin-mediated protection against ischemic injury in primary renal tubular epithelial cellsA C Breggia, D M Wojchowski, J Himmelfarb
Journal of Vascular Surgery|April 1, 1997
Aspirin enhances platelet-derived growth factor-induced vascular smooth muscle cell proliferationR Harvey, C E Bredenberg, L Couper, et al.
Molecular and Cellular Biology|June 1, 1987
Isolation and characterization of temperature-sensitive RNA polymerase II mutants of Saccharomyces cerevisiaeH J Himmelfarb, E M Simpson, J D Friesen
Free Radical Biology & Medicine|November 14, 2001
Myeloperoxidase-catalyzed 3-chlorotyrosine formation in dialysis patientsJ Himmelfarb, M E McMenamin, G Loseto, et al.
Kidney International|May 1, 1994
Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind studyR Sreedhara, J Himmelfarb, J M Lazarus, et al.
Cell|December 21, 1990
GAL11P: a yeast mutation that potentiates the effect of weak GAL4-derived activatorsH J Himmelfarb, J Pearlberg, D H Last, et al.
Pageof 6